SOX2 and breast carcinoma: Ling et al. (25) have demonstrated that the pluripotency markers, OCT3/4, Sox2 and Nanog, are expressed in three different breast cancer cell lines at various levels; however, a comparison between BCSCs and breast cancer cell lines has not been performed yet.